Pronađeno: 1-4 / 4 radova

Autori: Gaafar Rabab

>> Filter: Samo Article i Review

Naslov Afatinib in locally advanced/metastatic NSCLC harboring common EGFR mutations, after chemotherapy: a Phase IV study (Article)
Autori Thongprasert Sumitra  Geater Sarayut L  Clement Dana  Abdelaziz Amr  Reyes-Igama Jasmin  Jovanovic Dragana  Alexandru Aurelia  Schenker Michael  Sriuranpong Virote  Serwatowski Piotr  Suresh Sheethal  Cseh Agnieszka  Gaafar Rabab 
Info LUNG CANCER MANAGEMENT, (2019), vol. 8 br. 3, str. -
Projekat AstraZeneca; Roche; Boehringer Ingelheim; Novartis; Astra Zeneca; Astellas; Bristol Myers Squibb; Eli Lilly; Pfizer; AbbVie; Merck; Merck Serono; Bioven; Pharma Mar; Regeneron; Eisai; Amgern; Mylan
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Afatinib in chemotherapy pre-treated EGFR mutation-positive NSCLC (Meeting Abstract)
Autori Thongprasert Sumitra  Geater SL  Clement D  Abdelaziz A  Reyes-Igama J  Jovanovic D  Alexandru A  Schenker Michael  Sriuranpong Virote  Serwatowski P  Suresh S  Cseh Agnieszka  Gaafar Rabab 
Info ANNALS OF ONCOLOGY, (2018), vol. 29 br. , Suppl. 9, str. 146-146
Projekat Boehringer Ingelheim
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Second-line afatinib for patients with locally advanced or metastatic NSCLC harbouring common EGFR mutations: A phase IV study (Meeting Abstract)
Autori Thongprasert Sumitra  Geater SL  Clement D  Abdelaziz A  Reyer-Igama J  Jovanovic D  Suresh S  Cseh Agnieszka  Gaafar Rabab 
Info JOURNAL OF THORACIC ONCOLOGY, (2018), vol. 13 br. 4, Suppl. S, str. S94-S94
Projekat Boehringer Ingelheim
Ispravka ISI/Web of Science   Članak   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Naslov Phase IV Study of Afatinib in Locally Advanced or Metastatic Non-Small Cell Lung Cancer (Meeting Abstract)
Autori Thongprasert Sumitra  Boldeanu Cosmin  Radosavljevic Davorin Z  Petrovic Marina D  Jones Hilary  Cseh Agnieszka  Gaafar Rabab 
Info JOURNAL OF THORACIC ONCOLOGY, (2015), vol. 10 br. 9, Suppl. 2, str. S667-S667
Ispravka ISI/Web of Science   Elečas   Rang časopisa   Citati: ISI/Web of Science  
Ispis zapisa u formatu:TXT | BibTeX